These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6484357)

  • 21. [On the possibility of obtaining anti-tetanus immunotoxic sera from cow colostrum].
    Barabash VS
    Mikrobiol Zh; 1968; 30(6):565-6. PubMed ID: 5734168
    [No Abstract]   [Full Text] [Related]  

  • 22. [Development of the production of specific human immunoglobulins. II. Comparison of 3 technics for in vivo and in vitro titration of tetanus antitoxin].
    Pérez de la Mora C; Coria Jiménez R; Berrón Pérez R; González Pacheco M
    Rev Latinoam Microbiol; 1983; 25(4):213-20. PubMed ID: 6672939
    [No Abstract]   [Full Text] [Related]  

  • 23. Requirements for control of available bacterial products.
    Macheak ME
    J Am Vet Med Assoc; 1969 Jul; 155(2):433-5. PubMed ID: 5797158
    [No Abstract]   [Full Text] [Related]  

  • 24. Deterioration of tetanus antitoxin at 4-8 degrees C.
    Singh H; Maheshwari SC; Gupta RK
    J Biol Stand; 1982 Apr; 10(2):91-4. PubMed ID: 7096365
    [No Abstract]   [Full Text] [Related]  

  • 25. The influence of the method of preservation of erythrocytes on the correlation between tetanus antitoxin values as measured by passive haemagglutination and by seroneutralization tests in mice.
    Nyerges G; Lutter J
    J Biol Stand; 1980; 8(4):311-6. PubMed ID: 7204416
    [No Abstract]   [Full Text] [Related]  

  • 26. [Obtaining anti-tetanus gamma-globulin from the plasma of immunized donors].
    Kovtunovich LG; Karavanov AG; Nazarchuk LV
    Vrach Delo; 1971 Aug; 8():140-4. PubMed ID: 5143049
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay.
    Gupta RK; Siber GR
    Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Use of the toxin-binding inhibition test for estimation of tetanus antitoxin in serum].
    Fordymacka A
    Med Dosw Mikrobiol; 2000; 52(1):75-80. PubMed ID: 11107781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimization of the formulation for a candidate lyophilised tetanus toxoid reference preparation.
    Matejtschuk P; Malik K; Tierney R; Sloth Wilhelmsen E; Preneta-Blanc R; Rigsby P; Sesardic D
    Biologicals; 2009 Jan; 37(1):1-7. PubMed ID: 18805022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development studies of lyophilized standard diphtheria-tetanus-pertussis vaccines].
    Ozcengiz E; Unver D; Cayan HH; Atakan Ablay P; Kanik E
    Mikrobiyol Bul; 2007 Apr; 41(2):165-73. PubMed ID: 17682702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of 1-arterenol in a case of hypersensitivity to tetanus antitoxin.
    GUMPEL RC; KRISTAN JJ; LIPTON P
    Ann Intern Med; 1956 Feb; 44(2):406-10. PubMed ID: 13292849
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment of tetanus by lumbar intrathecal tetanus-antitoxin.
    Ogatuti P
    P N G Med J; 1980 Dec; 23(4):179-81. PubMed ID: 6937027
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Solubility of the lyophilized immune serum--concentration of the adjuvant and preservation of the lyophilized immune serum].
    Adachi H
    Nihon Saikingaku Zasshi; 1974 Jul; 29(4):671-80. PubMed ID: 4475144
    [No Abstract]   [Full Text] [Related]  

  • 34. [Kinetics of tetanus antitoxin after administration of specific immunoglobulins].
    Crovari P; Gasparini R; Della Rocca A; D'Aste E
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):493-7. PubMed ID: 7248078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
    Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
    Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vacuum packaged lyophilized viral antisera: evolution of a process.
    Starkey RJ
    Bull Parenter Drug Assoc; 1966; 20(2):39-47. PubMed ID: 5905227
    [No Abstract]   [Full Text] [Related]  

  • 37. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Collaborative study for the establishment of a European Pharmacopoeia Biological Reference Preparation for serological potency testing of tetanus vaccines for human use: Clostridium tetani guinea pig antiserum (human).
    Hendriksen C; van der Gun J; Winsnes R; Urdal T; Rautmann G; Esposito-Farese ME
    Pharmeuropa Spec Issue Biol; 2001 Aug; 2001(1):7-11. PubMed ID: 11705101
    [No Abstract]   [Full Text] [Related]  

  • 39. Quantitation of tetanus and diphtheria antitoxins in mouse sera by indirect haemagglutination.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Mar; 30(1):23-8. PubMed ID: 9842161
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Change in the physico-chemical properties of antitoxic tetanus sera during preservation].
    Smakotina ZV
    Lab Delo; 1969; 4():245. PubMed ID: 4184933
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.